BioHealth News Archive
Trump order threatens small biotechs driving COVID innovation | TheHill
Pfizer’s disclosure last week that it may reverse plans to in-shore manufacturing facilities and science jobs to the United States is just the tip…
Read More
Novavax Announces Positive Phase 1 Data for its COVID-19 Vaccine Candidate | Novavax Inc. – IR Site
GAITHERSBURG, Md., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today…
Read More
TruGenomix co-founders hope to prevent severe PTSD – Sanford Health News
The two co-founders behind TruGenomix have a vision for helping veterans and others who might be prone to post-traumatic stress disorder (PTSD). A new…
Read More
Lurie Prize in Biomedical Sciences | FNIH
Each year, the FNIH recognizes outstanding achievements by a promising young scientist in biomedical research by bestowing the Lurie Prize in Biomedical Sciences, a…
Read More
Is Telemedicine Here to Stay?
Telemedicine is having its moment. Over the last few months, millions of people have relied on video or telephone calls to talk to their…
Read More
REGENXBIO Announces Additional Positive Interim Phase I/IIa Trial Update and Program Updates for RGX-314 for the Treatment of Wet AMD | BioSpace
REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary…
Read More
Save the Date! 2020 BioHealth Capital Region Forum
This invitation-only event is free for executive level biotech leaders and is presented by BioHealth Innovation, Virginia Bio, Children’s National Health System, Johns Hopkins…
Read More
Jennifer Butler, Executive Vice President and General Manager, Innate Pharma US Inc. sits down with Rich Bendis for BioTalk
Jennifer Butler, Executive Vice President and General Manager, Innate Pharma US Inc. joins Rich Bendis on BioTalk to discuss her career, bringing Innate from…
Read MoreNIH Invests $248.7 Million to Ramp up COVID-19 Testing
Six months into the COVID-19 pandemic, the question of why tests that detect the presence of the SARS-CoV-2 virus are not faster, better, and…
Read More
EXCLUSIVE! A Personal Interview with Rita Colwell in Advance of Her Book “A Lab of One’s Own”
Rita Colwell is perhaps best known for her research on the pathogenic bacterium Vibrio cholerae. But the designation of pioneer is a label befitting Colwell…
Read More
5 Questions with Jamie Lacey-Moreira, Principal and Founder, PressComm PR, LLC · BioBuzz
“5 Questions With……” is a weekly BioBuzz series where we reach out to interesting people in the BioHealth Capital Region to share a little…
Read More
BioFactura Awarded $1 Million SBIR Contract for Development of a Marburg Virus Therapeutic
FREDERICK, Md., July 29, 2020 /PRNewswire-PRWeb/ -- BioFactura, Inc. today announced a $1 million Small Business Innovation Research (SBIR) Phase II contract awarded by…
Read MoreJohns Hopkins Ranks 3rd In The Nation’s Best Hospitals List – CBS Baltimore
BALTIMORE (WJZ) — Johns Hopkins Hospital ranked no. 3 among the nation’s best hospitals, according to U.S. News & World Report. The Best Hospitals…
Read More
TEDCO Announces New Executives | Maryland | curated.tncontentexchange.com
COLUMBIA, Md., July 28, 2020 /PRNewswire/ -- TEDCO, Maryland's economic engine for technology companies, announced today the appointments of Michael Hauser as the Managing Director…
Read More
Biobuzz Directory – HemoShear Therapeutics Receives FDA Fast Track and Rare Pediatric Disease Designations for HST5040 to Treat Methylmalonic Acidemia and Propionic Acidemia
Charlottesville, Va., July 28, 2020 – HemoShear Therapeutics, a clinical stage company developing treatments for rare metabolic disorders, has received Fast Track and Rare Pediatric…
Read More